A Kato1, H Yoshidome, M J Edwards, A B Lentsch. 1. Department of Surgery, University of Louisville School of Medicine, J. G. Brown Cancer Center, Kentucky 40202, USA.
Abstract
OBJECTIVE AND DESIGN: The ability of interleukin-4 (IL-4) to modulate activation of the transcription factors, NF-kappaB and STAT6, reduce proinflammatory cytokine expression and protect against liver injury induced by ischemia/reperfusion was assessed. MATERIALS AND SUBJECTS: C57BL/6 mice underwent 90 minutes of partial hepatic ischemia followed by 1 or 8 h of reperfusion with or without intravenous administration of 1 microg (0.5 microg just prior to ischemia, 0.5 microg at reperfusion) recombinant murine IL-4. Liver expression of TNFalpha mRNA was determined by RT-PCR. Activation of NF-kappaB and STAT6 in liver nuclear extracts was assessed by mobility shift assay. RESULTS: Hepatic ischemia/reperfusion increased hepatic expression of tumor necrosis factor-alpha (TNFalpha), induced significant neutrophil accumulation and liver injury. Treatment with IL-4 greatly suppressed liver TNFalpha mRNA expression, neutrophil accumulation and liver injury. IL-4 had no effect on liver NF-kappaB activation, but greatly increased the activation of STAT6. CONCLUSIONS: The data suggest that STAT6 activation by IL-4 may be responsible for the protective effects of this cytokine.
OBJECTIVE AND DESIGN: The ability of interleukin-4 (IL-4) to modulate activation of the transcription factors, NF-kappaB and STAT6, reduce proinflammatory cytokine expression and protect against liver injury induced by ischemia/reperfusion was assessed. MATERIALS AND SUBJECTS: C57BL/6 mice underwent 90 minutes of partial hepatic ischemia followed by 1 or 8 h of reperfusion with or without intravenous administration of 1 microg (0.5 microg just prior to ischemia, 0.5 microg at reperfusion) recombinant murineIL-4. Liver expression of TNFalpha mRNA was determined by RT-PCR. Activation of NF-kappaB and STAT6 in liver nuclear extracts was assessed by mobility shift assay. RESULTS:Hepatic ischemia/reperfusion increased hepatic expression of tumor necrosis factor-alpha (TNFalpha), induced significant neutrophil accumulation and liver injury. Treatment with IL-4 greatly suppressed liver TNFalpha mRNA expression, neutrophil accumulation and liver injury. IL-4 had no effect on liver NF-kappaB activation, but greatly increased the activation of STAT6. CONCLUSIONS: The data suggest that STAT6 activation by IL-4 may be responsible for the protective effects of this cytokine.
Authors: Nan N Zhang; Nong Y Huang; Xi K Zhou; Xiao L Luo; Chang Y Liu; Yan Zhang; Ji Qiu; Yin B Zhang; Xiu Teng; Can Luo; Xian C Chen; Bing Kan; Yong Q Mao; Ai P Tong; Yu Q Wei; Jiong Li Journal: Inflamm Res Date: 2011-09-24 Impact factor: 4.575
Authors: Robert A DeAngelis; Maciej M Markiewski; Ioannis Kourtzelis; Stavros Rafail; Maria Syriga; Adam Sandor; Mano R Maurya; Shakti Gupta; Shankar Subramaniam; John D Lambris Journal: J Immunol Date: 2011-12-19 Impact factor: 5.422
Authors: Pauline M Ryan; Mohammed Bourdi; Midhun C Korrapati; William R Proctor; Ronald A Vasquez; Steven B Yee; Timothy D Quinn; Mala Chakraborty; Lance R Pohl Journal: Chem Res Toxicol Date: 2011-12-13 Impact factor: 3.739
Authors: Zubin M Bamboat; Lee M Ocuin; Vinod P Balachandran; Hebroon Obaid; George Plitas; Ronald P DeMatteo Journal: J Clin Invest Date: 2010-01-19 Impact factor: 14.808